These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27816940)

  • 1. Does Methylphenidate Reduce Testosterone Levels in Humans? A Prospective Study in Children with Attention-Deficit/Hyperactivity Disorder.
    Wang LJ; Chou MC; Chou WJ; Lee MJ; Lin PY; Lee SY; Lee YH
    Int J Neuropsychopharmacol; 2017 Mar; 20(3):219-227. PubMed ID: 27816940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential disturbance of methylphenidate of gonadal hormones or pubescent development in patients with attention-deficit/hyperactivity disorder: A twelve-month follow-up study.
    Wang LJ; Huang YH; Chou WJ; Lee SY; Tsai CS; Lee MJ; Chou MC
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110181. PubMed ID: 33227299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of salivary dehydroepiandrosterone levels and symptoms in patients with attention deficit hyperactivity disorder during six months of treatment with methylphenidate.
    Wang LJ; Hsiao CC; Huang YS; Chiang YL; Ree SC; Chen YC; Wu YW; Wu CC; Shang ZY; Chen CK
    Psychoneuroendocrinology; 2011 Sep; 36(8):1209-16. PubMed ID: 21411231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mullerian inhibiting substance, sex hormone binding globulin and sex hormone levels in stimulant-naïve, first-diagnosed prepubertal boys with attention-deficit/hyperactivity disorder: comparison with matched healthy controls as well as before and after oros-methylpenidate treatment.
    Gokcen C; Erbagci AB; Mutluer T; Orkmez M; Correll CU
    Int J Psychiatry Clin Pract; 2019 Nov; 23(4):251-257. PubMed ID: 31339400
    [No Abstract]   [Full Text] [Related]  

  • 5. Salivary neurosteroid levels and behavioural profiles of children with attention-deficit/hyperactivity disorder during six months of methylphenidate treatment.
    Wang LJ; Wu CC; Lee SY; Tsai YF
    J Child Adolesc Psychopharmacol; 2014 Aug; 24(6):336-40. PubMed ID: 24956271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study.
    Inglis SK; Carucci S; Garas P; Häge A; Banaschewski T; Buitelaar JK; Dittmann RW; Falissard B; Hollis C; Kovshoff H; Liddle E; McCarthy S; Nagy P; Neubert A; Rosenthal E; Sonuga-Barke E; Wong I; Zuddas A; Coghill DC;
    BMJ Open; 2016 Apr; 6(4):e010433. PubMed ID: 27118284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep and daytime sleepiness in methylphenidate medicated and un-medicated children with attention-deficit/hyperactivity disorder (ADHD).
    Cockcroft K; Ashwal J; Bentley A
    Afr J Psychiatry (Johannesbg); 2009 Nov; 12(4):275-9. PubMed ID: 20033109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testicular Function After Long-Term Methylphenidate Treatment in Boys with Attention-Deficit/Hyperactivity Disorder.
    Wang LJ; Lee SY; Chou WJ; Lee MJ; Tsai CS; Lee TL; Yang CJ; Yang KC; Chen CK; Shyu YC
    J Child Adolesc Psychopharmacol; 2019 Aug; 29(6):433-438. PubMed ID: 30575416
    [No Abstract]   [Full Text] [Related]  

  • 9. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
    Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective, naturalistic study of open-label OROS methylphenidate treatment in Chinese school-aged children with attention-deficit/hyperactivity disorder.
    Zheng Y; Wang YF; Qin J; Wang LW; Zou LP; Jin XM; Xu T; Wang Y; Qi YL; Gong ME; Yin QY; Mai JN; Jing J; Luo XY; Ma HW; Li HB; Xie L; Li Y; Kuang GF; Yi MJ; Wang F; Zhu XH; Yao YB
    Chin Med J (Engl); 2011 Oct; 124(20):3269-74. PubMed ID: 22088519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
    Storebø OJ; Ramstad E; Krogh HB; Nilausen TD; Skoog M; Holmskov M; Rosendal S; Groth C; Magnusson FL; Moreira-Maia CR; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Forsbøl B; Simonsen E; Gluud C
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009885. PubMed ID: 26599576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Treatment Outcome in Adult Male Prisoners With Attention-Deficit/Hyperactivity Disorder: Three-Year Naturalistic Follow-Up of a 52-Week Methylphenidate Trial.
    Ginsberg Y; Långström N; Larsson H; Lindefors N
    J Clin Psychopharmacol; 2015 Oct; 35(5):535-43. PubMed ID: 26284932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
    Swanson JM; Wigal SB; Wigal T; Sonuga-Barke E; Greenhill LL; Biederman J; Kollins S; Nguyen AS; DeCory HH; Hirshe Dirksen SJ; Hatch SJ;
    Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum brain-derived neurotrophic factor levels in treatment-naïve boys with attention-deficit/hyperactivity disorder treated with methylphenidate: an 8-week, observational pretest-posttest study.
    Akay AP; Resmi H; Güney SA; Erkuran HÖ; Özyurt G; Sargin E; Topuzoglu A; Tufan AE
    Eur Child Adolesc Psychiatry; 2018 Jan; 27(1):127-135. PubMed ID: 28710695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371].
    Akhondzadeh S; Mohammadi MR; Khademi M
    BMC Psychiatry; 2004 Apr; 4():9. PubMed ID: 15070418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Epstein T; Patsopoulos NA; Weiser M
    Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.
    Soutullo C; Banaschewski T; Lecendreux M; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Bloomfield R; Squires LA; Coghill DR
    CNS Drugs; 2013 Sep; 27(9):743-51. PubMed ID: 23801529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of methylphenidate on social cognition and oxytocin in children with attention deficit hyperactivity disorder.
    Levi-Shachar O; Gvirts HZ; Goldwin Y; Bloch Y; Shamay-Tsoory S; Zagoory-Sharon O; Feldman R; Maoz H
    Neuropsychopharmacology; 2020 Jan; 45(2):367-373. PubMed ID: 31514201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of methylphenidate on growth of school age children with attention deficit hyperactivity disorder].
    Zhang HY; Du ML; Zhuang SQ; Liu MN
    Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):723-7. PubMed ID: 16255846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder.
    Kariyawasam SH; Zaw F; Handley SL
    Neuro Endocrinol Lett; 2002 Feb; 23(1):45-8. PubMed ID: 11880861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.